Salt: Lamivudine
Therapeutic Description: Antivirals, Systemics
Category: Nucleoside reverse transcriptase inhibitor.
Pregnancy: No evidence of risk in humans.
Lactation: Caution advised or effect undetermined.
Precautions: Initiate treatment under specialist supervision. Renal impairment, advanced liver disease due to Hep. B, pancreatitis.
Adjunct to other antiretroviral agents in progressive HIV disease.
Adults: 300 mg daily preferably with
IV ganciclovir, foscarnet, co-trimoxazole.
Neutropenia, anaemia, thrombocytopenia. Raised liver enzymes, serum amylase. Headache, malaise, fatigue, GI upset, abdominal pain, insomnia, cough, nasal symptoms, musculoskeletal pain, pancreatitis, peripheral neuropathy.
Strength Pack Size PKR
100 mg14's1654.14

Your medicine formula resulted in the following types of medicine type. Please select to proceed.